Lumacaftor Monotherapy Achieves Bioequivalence to Approved Combination Formulation in Healthy Adults
A randomized crossover trial in healthy volunteers confirmed that an oral lumacaftor monosubstance formulation delivers bioequivalent drug exposure to the ...

